Clinical Trials Logo
  1. Home
  2. Acute Renal Injury
  3. NCT02838667
  4. Details
NCT02838667 Clinical Trial

Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)

Acute Renal Injury Clinical Trial

Official title:
Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02838667
Other study ID # 16-003845
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2016
Est. completion date June 10, 2019

Study information
Verified date October 2019
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nephrology participation in care of patients undergoing CABG could reduce AKI through correction of modifiable risk factors and early detection and intervention of post-op AKI.

Recruitment information / eligibility
Status Completed
Enrollment 2300
Est. completion date June 10, 2019
Est. primary completion date June 10, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients (Age >18 years)

- Elective CABG at Mayo Clinic Rochester and Shanghai Zhongshan Hospital from 7/1/2016 to 6/30/2017

Exclusion Criteria:

- Non-elective CABG

- Renal failure on dialysis

- Renal transplantation

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Standard of Care plus Nephrology Care

Locations
Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Perfusion pressures (mean arterial pressure) = 65-70 mmHg baseline to 5 days
See also
  Status Clinical Trial Phase
Completed NCT01920542 - Dexmedetomidine on Pediatric Heart Operation N/A
Recruiting NCT04334707 - Kidney Precision Medicine Project
Completed NCT02765464 - Acute Kidney Injury in Critically Ill Patients
Recruiting NCT05970952 - Acute Kidney Injury in Intensive Care Patients
Recruiting NCT05145283 - Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation Phase 2
Active, not recruiting NCT05384899 - Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Completed NCT04600271 - Acute Renal Injury After Major Elective Non-Cardiac Surgery
Not yet recruiting NCT05666232 - Renal and Cardiac Risk Factors of AKI After Liver Transplantation
Completed NCT02974946 - Kidney Protection Using the RenalGuard® System in Cardiac Surgery N/A
Recruiting NCT05186636 - Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans
Completed NCT01807195 - Acute Renal Injury Associated Contrast in Intensive Care Unit Patients N/A
Not yet recruiting NCT05308810 - Postoperative Kidney Functions in Geriatric Major Gynecologic-Oncologic Surgery
Recruiting NCT02743156 - Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy Phase 4
Recruiting NCT02417896 - Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery N/A

External Links